FDA commissioner nominee Robert Califf toes the line on evaluating sunscreen ingredients, telling Senate members the agency is open to moving quickly when sponsors provide the appropriate safety and efficacy evidence.
Califf emphasized evidence supporting sunscreen ingredient applications during his Nov. 17 confirmation hearing before the Senate Health, Education, Labor and Pensions Committee, a civil and at times jovial event absent...